Consolidated Financial Statements ended 31 December 2017, which have been audited by the Company’s authorized auditor. The company would like to clarify the operating results of the Company and its subsidiary
Company Limited (“the Company”) and its Subsidiary (“the Group”) would like to clarify the change in operating result for the 2nd Quarter ended 30 June 2020, which changed in revenue and net profit compared
calculated from the profitability potential based on the operating profit (EBITDA) of WICE SG at the end of 2016 - 2018.The transaction size of the share value in part 2 is equal to 5,354,375 Singapore dollars
21.54% from the same period of previous year. The total revenue of each operating segments for the nine-month period ended 30 September 2019 of the Company and its subsidiaries had changed from the
the two languages, the Thai version shall prevail. The objective of this MD&A is to present the information and the explanation of financial status and operating results as of the date hereof. However
borrowing of loans, giving guarantees and/or undertaking in accordance with the terms and conditions stipulated in the Equity Purchase Agreement. On 26 February 2018, the Company, entered into Equity Purchase
in consider of long-term development of the Company group and to enhance the operating efficiency, as per the Notifications of the Stock Exchange of Thailand regarding Rules, Conditions and Procedures
Arrangement, Operating Systems and Providing Services of Securities and Derivatives Intermediaries dated 6 September 2556, the SEC hereby issues the following regulations: Clause 1 In this Notification
(October – December 2018) and clarification of the operating result change excess 20%. Dear Sirs, We gladly inform to report our 2nd quarter performance figure during October – December 2018, ending December
The Stock Exchange of Thailand The operating performance for three-month period end 30 September 2019 of Mahachai Hospital Public Company Limited compared to the prior year was increasing in net profit